Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Prepaid Assets (2016 - 2025)

Sangamo Therapeutics (SGMO) has 16 years of Prepaid Assets data on record, last reported at $8.4 million in Q3 2025.

  • For Q3 2025, Prepaid Assets changed 0.13% year-over-year to $8.4 million; the TTM value through Sep 2025 reached $8.4 million, changed 0.13%, while the annual FY2024 figure was $5.2 million, 44.11% down from the prior year.
  • Prepaid Assets reached $8.4 million in Q3 2025 per SGMO's latest filing, up from $6.6 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $21.1 million in Q2 2022 and bottomed at $5.2 million in Q4 2024.
  • Average Prepaid Assets over 5 years is $12.8 million, with a median of $12.6 million recorded in 2024.
  • Peak YoY movement for Prepaid Assets: surged 146.65% in 2021, then tumbled 49.19% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $15.9 million in 2021, then rose by 14.91% to $18.2 million in 2022, then plummeted by 49.19% to $9.3 million in 2023, then crashed by 44.11% to $5.2 million in 2024, then surged by 62.76% to $8.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $8.4 million in Q3 2025, $6.6 million in Q2 2025, and $7.8 million in Q1 2025.